Evidence map›Paper›PMID 22918968›Full record

ArticleMolecular pharmacology2012

Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity.

Manju Sharma, Vidya Gadang, Anja Jaeschke

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. The Role of Mechanistic Biomarkers in Understanding Acetaminophen Hepatotoxicity in Humans.Drug metabolism and disposition: the biological fate of chemicals · 2024
    Review
  3. Review
  4. Mitochondrial P-JNK target, SAB (SH3BP5), in regulation of cell death.Frontiers in cell and developmental biology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. c-Antioxidants & redox signaling · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. A multiplier peroxiporin signal transduction pathway powers piscine spermatozoa.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Cell Death in Liver Diseases: A Review.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Article
  19. Observational
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Manju SharmaDepartment of Pathology, Metabolic Diseases Institute, University of Cincinnati, Cincinnati, Ohio 45237, USA.
Vidya Gadang
Anja Jaeschke
University of Cincinnati · US

Funding

MLK3 in metabolic stress signalingR01DK082583 · NIDDK · UNIVERSITY OF CINCINNATI · PI JAESCHKE, ANJA · 2010 to 2014
$1.7M
NIDDK NIH HHS DK082583NIDDK NIH HHS R01 DK082583
6 · The paper itself

Abstract

c-Jun NH(2)-terminal kinase (JNK) activation plays a major role in acetaminophen (APAP)-induced hepatotoxicity. However, the exact mechanism of APAP-induced JNK activation is incompletely understood. It has been established that apoptosis signal-regulating kinase 1 (ASK1) regulates the late phase of APAP-induced JNK activation, but the mitogen-activated protein kinase kinase kinase that mediates the initial phase of APAP-induced JNK activation has not been identified. Oxidative stress produced during APAP metabolism causes JNK activation, which promotes mitochondrial dysfunction and results in the amplification of oxidative stress. Therefore, inhibition of the initial phase of JNK activation may be key to protection against APAP-induced liver injury. The goal of this study was to determine whether mixed-lineage kinase 3 (MLK3) mediates the initial, ASK1-independent phase of APAP-induced JNK activation and thus promotes drug-induced hepatotoxicity. We found that MLK3 was activated by oxidative stress and was required for JNK activation in response to oxidative stress. Loss of MLK3 attenuated APAP-induced JNK activation and hepatocyte death in vitro, independent of receptor-interacting protein 1. Moreover, JNK and glycogen synthase kinase 3β activation was significantly attenuated, and Mcl-1 degradation was inhibited in APAP-treated MLK3-knockout mice. Furthermore, we showed that loss of MLK3 increased expression of glutamate cysteine ligase, accelerated hepatic GSH recovery, and decreased production of reactive oxygen species after APAP treatment. MLK3-deficient mice were significantly protected from APAP-induced liver injury, compared with wild-type mice. Together, these studies establish a novel role for MLK3 in APAP-induced JNK activation and hepatotoxicity, and they suggest MLK3 as a possible target in the treatment of APAP-induced liver injury.

Indexed as

AcetaminophenAnimalsCell Line, TumorChemical and Drug Induced Liver InjuryEnzyme ActivationGlutathioneGTPase-Activating ProteinsJNK Mitogen-Activated Protein KinasesMaleMAP Kinase Kinase Kinase 5MAP Kinase Kinase KinasesMiceMice, Inbred C57BLMice, KnockoutMitogen-Activated Protein Kinase Kinase Kinase 11Myeloid Cell Leukemia Sequence 1 ProteinAcetaminophenGlutathioneGTPase-Activating ProteinsJNK Mitogen-Activated Protein KinasesMAP Kinase Kinase Kinase 5MAP Kinase Kinase KinasesMcl1 protein, mouseMitogen-Activated Protein Kinase Kinase Kinase 11Myeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2Ralbp1 protein, mouseReactive Oxygen Species

Identifiers

PMID22918968
PMCPMC3477232
OpenAlexW2124308362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.